MELISSA DUBOIS: Open Payments
NPI 1871988360 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$960 in 42 payments from 16 companies in 2025. Trend: 2023 $1,308 · 2024 $1,206 · 2025 $960
Food & beverage: $960
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $236 |
| ABBVIE INC. | 8 | $196 |
| PFIZER INC. | 4 | $87 |
| Lilly USA, LLC | 4 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Amgen Inc. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $45 |
| Antares Pharma, Inc. | 2 | $42 |
| Pulmonx Corporation | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
Products named: Wegovy, QULIPTA, UBRELVY, MOUNJARO, NURTEC ODT, TRINTELLIX, Ozempic, Veozah.
Industry payments across GA — which companies pay providers there.
